JP2022521353A5 - - Google Patents
Info
- Publication number
- JP2022521353A5 JP2022521353A5 JP2021559471A JP2021559471A JP2022521353A5 JP 2022521353 A5 JP2022521353 A5 JP 2022521353A5 JP 2021559471 A JP2021559471 A JP 2021559471A JP 2021559471 A JP2021559471 A JP 2021559471A JP 2022521353 A5 JP2022521353 A5 JP 2022521353A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- peptide
- amino acid
- domain
- items
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022063931A JP2022082754A (ja) | 2019-03-22 | 2022-04-07 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
| JP2024123197A JP2024149556A (ja) | 2019-03-22 | 2024-07-30 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962822241P | 2019-03-22 | 2019-03-22 | |
| US62/822,241 | 2019-03-22 | ||
| US201962865469P | 2019-06-24 | 2019-06-24 | |
| US62/865,469 | 2019-06-24 | ||
| PCT/US2020/024053 WO2020198074A1 (en) | 2019-03-22 | 2020-03-20 | D-peptidic compounds for vegf |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022063931A Division JP2022082754A (ja) | 2019-03-22 | 2022-04-07 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
| JP2024123197A Division JP2024149556A (ja) | 2019-03-22 | 2024-07-30 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521353A JP2022521353A (ja) | 2022-04-06 |
| JP2022521353A5 true JP2022521353A5 (https=) | 2023-03-29 |
Family
ID=70285984
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559471A Pending JP2022521353A (ja) | 2019-03-22 | 2020-03-20 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
| JP2022063931A Ceased JP2022082754A (ja) | 2019-03-22 | 2022-04-07 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
| JP2024123197A Pending JP2024149556A (ja) | 2019-03-22 | 2024-07-30 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022063931A Ceased JP2022082754A (ja) | 2019-03-22 | 2022-04-07 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
| JP2024123197A Pending JP2024149556A (ja) | 2019-03-22 | 2024-07-30 | Ｖｅｇｆのためのｄ－ペプチド性化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210061861A1 (https=) |
| EP (1) | EP3941580A1 (https=) |
| JP (3) | JP2022521353A (https=) |
| KR (2) | KR20220044612A (https=) |
| CN (3) | CN119930814A (https=) |
| TW (3) | TW202523683A (https=) |
| WO (1) | WO2020198074A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022310346A1 (en) | 2021-07-14 | 2024-01-25 | Lycia Therapeutics, Inc. | M6pr cell surface receptor binding compounds and conjugates |
| KR102662922B1 (ko) * | 2022-05-31 | 2024-05-03 | 주식회사 세네릭스 | 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물 |
| CN120835794A (zh) | 2023-01-18 | 2025-10-24 | 利西亚治疗公司 | M6pr结合化合物和缀合物 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT672141E (pt) | 1992-10-23 | 2003-09-30 | Immunex Corp | Metodos de preparacao de proteinas oligomericas soluveis |
| SE9400088D0 (sv) | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
| US6740734B1 (en) | 1994-01-14 | 2004-05-25 | Biovitrum Ab | Bacterial receptor structures |
| US6811779B2 (en) | 1994-02-10 | 2004-11-02 | Imclone Systems Incorporated | Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| GB9708265D0 (en) | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US6887470B1 (en) | 1999-09-10 | 2005-05-03 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| EP2213743A1 (en) | 2000-04-12 | 2010-08-04 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US20050054051A1 (en) | 2001-04-12 | 2005-03-10 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| AU2003278807A1 (en) * | 2002-03-01 | 2004-08-13 | Bracco International B.V. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| US20030191056A1 (en) | 2002-04-04 | 2003-10-09 | Kenneth Walker | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| US8545809B2 (en) | 2007-01-11 | 2013-10-01 | Immunomedics, Inc. | Methods and compositions for improved 18F labeling of proteins, peptides and other molecules |
| EP2077272A1 (en) | 2007-12-21 | 2009-07-08 | Affibody AB | Polypeptide libraries with a predetermined scaffold |
| EP2324048A2 (en) * | 2008-07-30 | 2011-05-25 | Cosmix Therapeutics Llc | Peptide therapeutics that bind vegf and methods of use thereof |
| EP2638063A4 (en) * | 2010-11-12 | 2014-04-23 | Reflexion Pharmaceuticals Inc | GB1 PEPTIDE LIBRARIES AND CONNECTIONS AND SCREENING METHOD THEREFOR |
| WO2014071234A1 (en) * | 2012-11-02 | 2014-05-08 | The Governing Council Of The University Of Toronto | Gb1 peptidic compounds and methods for making and using the same |
| WO2014140882A2 (en) | 2013-03-14 | 2014-09-18 | The Governing Council Of The University Of Toronto | Scaffolded peptidic libraries and methods of making and screening the same |
| MX367423B (es) | 2013-08-28 | 2019-08-21 | Affibody Ab | Polipeptidos de union a c5. |
| WO2015112700A1 (en) * | 2014-01-22 | 2015-07-30 | Wisconsin Alumni Research Foundation | Alpha/beta-peptide mimics of z-domain peptides |
| WO2016059068A1 (en) * | 2014-10-13 | 2016-04-21 | Affibody Ab | Vegfr-2 binding polypeptides |
| JP2016123342A (ja) * | 2014-12-26 | 2016-07-11 | 国立研究開発法人産業技術総合研究所 | Ｖｅｇｆ結合性ペプチド |
| KR102427117B1 (ko) * | 2015-04-02 | 2022-07-29 | 몰리큘라 파트너스 아게 | 혈청 알부민에 대한 결합 특이성을 갖는 설계된 안키린 반복 도메인 |
| WO2016208761A1 (ja) * | 2015-06-25 | 2016-12-29 | 公立大学法人大阪府立大学 | 薬物複合体 |
-
2020
- 2020-03-20 KR KR1020227010018A patent/KR20220044612A/ko not_active Ceased
- 2020-03-20 EP EP20719049.7A patent/EP3941580A1/en active Pending
- 2020-03-20 US US16/826,050 patent/US20210061861A1/en not_active Abandoned
- 2020-03-20 CN CN202411356232.0A patent/CN119930814A/zh active Pending
- 2020-03-20 KR KR1020217034326A patent/KR20220029545A/ko not_active Ceased
- 2020-03-20 JP JP2021559471A patent/JP2022521353A/ja active Pending
- 2020-03-20 CN CN202080038052.1A patent/CN114174334A/zh active Pending
- 2020-03-20 WO PCT/US2020/024053 patent/WO2020198074A1/en not_active Ceased
- 2020-03-20 CN CN202210386453.7A patent/CN114989298A/zh active Pending
- 2020-03-23 TW TW113131876A patent/TW202523683A/zh unknown
- 2020-03-23 TW TW111112117A patent/TWI820657B/zh active
- 2020-03-23 TW TW109109687A patent/TW202102532A/zh unknown
-
2022
- 2022-04-07 JP JP2022063931A patent/JP2022082754A/ja not_active Ceased
-
2024
- 2024-07-30 JP JP2024123197A patent/JP2024149556A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7775358B2 (ja) | 単一ドメイン血清アルブミン結合タンパク質 | |
| AU2021286418B2 (en) | Designed ankyrin repeat domains with binding specificity for serum albumin | |
| KR102365977B1 (ko) | 단일 쇄 가변 단편 cd3 결합 단백질 | |
| KR101997241B1 (ko) | 삼중특이성 결합 단백질 및 사용 방법 | |
| JP6486908B2 (ja) | 肝細胞増殖因子に結合する設計アンキリン反復タンパク質 | |
| US20240084009A1 (en) | Single chain variable fragment cd3 binding proteins | |
| CN110835375B (zh) | 一种抗pd-1/egfr双特异性抗体及其用途 | |
| JP2021508458A (ja) | Ｒｏｒ１特異性抗原結合分子 | |
| KR20150091138A (ko) | Her2에 대항하는 적어도 두 개 이상의 반복 도메인을 포함하는 결합 단백질 | |
| EP2486058A1 (en) | Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same | |
| JP2022521353A5 (https=) | ||
| TWI825459B (zh) | 一種SIRPα-Fc融合蛋白 | |
| JP6032735B2 (ja) | Ｖｅｇｆ結合性融合ペプチド | |
| JP2016027801A (ja) | 改良された抗血清アルブミン結合変異体 | |
| KR20180068982A (ko) | 혈관신생 인자에 대한 매우 강력한 모노클로날 항체 | |
| TW201742958A (zh) | 功能性抗體片段的高通量篩選方法及其免疫偶聯物以及用於篩選之適體-藥物偶聯物 | |
| TWI867218B (zh) | 靶向her2的抗原結合建構體及用途 | |
| JP7119225B2 (ja) | Ｐｄｇｆ受容体に対する抗体およびその用途 | |
| CN114025795B (zh) | 使用靶向her2的双特异性抗原结合构建体治疗胆道癌的方法 | |
| JP2026500703A (ja) | 融合タンパク質 | |
| JP2017043625A (ja) | Ｖｅｇｆ結合性ペプチド | |
| WO2016059068A1 (en) | Vegfr-2 binding polypeptides | |
| WO2016059057A1 (en) | Vegfr-2 binding polypeptides | |
| RU2852383C1 (ru) | Бифункциональный слитый белок и его применение | |
| KR20130097628A (ko) | 아포리포단백질을 포함하는 항체-약물 결합체 |